![JMCP Bloomberg Article: Drugmakers, Medicare Conclude Talks to Slash Spiraling Costs](https://amcp.org/sites/default/files/styles/card_fullsize/public/images/bloomberg-article-drugmakers.jpg.webp?itok=dsP0_WIp)
Hernandez co-authored a June study in the Journal of Managed Care & Specialty Pharmacy (JMCP) on price benchmarks for selected drugs and their therapeutic alternatives, which concluded different negotiation scenarios for the first 10 drugs. If a drug has a therapeutic alternative, that likely guided the initial price offer from the CMS.